vz
contact

Translational Gastroenterology Unit

Translational Gastroenterology Unit — clinical and experimental IBD research within Experimental Medicine / NDM at Oxford.

  • longIBD

    Longitudinal work on inflammatory bowel disease — connecting clinical phenotypes, immune mechanisms, and computational approaches to better understand disease course and classification, with a particular focus on anti–IL-10 IBD. Includes biomarker trajectories, patient-reported outcomes, and related longitudinal measures.

  • Neutralising autoantibodies against IL-10 and HLA-DRB1*01:03 in paediatric patients with inflammatory bowel disease

    Gharahdaghi N., Yeh P.J., Vadakethala K., Coy M., Kabiri L., Naz B., Jayamanne C., Hansson L., Zouboulis V., Rodrigues A., Howarth L., Alqahtani F., Ghate A., Vázquez López F., Green Z., Beattie R.M., Gasparetto M., Nedelkopoulou N., Iyengar A., Gopan A., Croft N.M., Grimaldi C., Kammermeier J., Jones K., Barendregt D.M.H., Chen M., Barnardo M., Zhang Q., Fachal L., Anderson C.A., Adams A., Johnson H., Gordon H., Tal N., Renji E., Wilson D.C., Henderson P., Muhammed R., Lee K.Y., Kapoor A., Levi R., Zilbauer M., Griffiths A.M., Turner D., Hambleton S., Doffinger R., Samsom J.N., UK PIBD BioResource, Parkes M., Travis S.P., Shouval D.S., de Ridder L., Muise A., Snapper S.B., Ashton J.J., Ennis S., Uhlig H.H.

    Gut

    2026 cited 1
  • Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease

    Gharahdaghi N., Yeh P.J., Ceron-Gutierrez L., Griffin H., Gordon H., Jayamanne C., Fracchia A., Chong A.Y., Walsh A., Brain O., Baker K., Kockelbergh H., Luo Y., Guevara Becerra M., Vadakethala K., Coy M., Kabiri L., Barnardo M., Dunachie S., Kronsteiner B., Adams A., Fowler D., Zhang Q., Fachal L., Anderson C.A., Desoki R., Vestergaard M.V., Larsen L., Wyatt N.J., Lees R.D., Mulligan R.J., Dong C., Sharip M.T., Faustini S.E., Shields A., Pakpoor J., Naz B., Richter A., Satsangi J., Lamb C.A., Parkes M., Powrie F., Mentzer A.J., Sazonovs A., Jess T., Klenerman P., Travis S., Hambleton S., Doffinger R., Uhlig H.H.

    New England Journal of Medicine

    2026 cited 11
  • Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease

    Griffin H., Ceron-Gutierrez L., Gharahdaghi N., Ebrahimi S., Davies S., Loo P.S., Szabo A., Williams E., Mukhopadhyay A., McLoughlin L., Irwin S., Travis S., Klenerman P., Bunn S., Cant A.J., Hambleton S., Uhlig H.H., Doffinger R.

    New England Journal of Medicine

    2024 cited 61
  • An Integrated Taxonomy for Monogenic Inflammatory Bowel Disease

    Bolton C., Smillie C.S., Pandey S., Elmentaite R., Wei G., Argmann C., Aschenbrenner D., James K.R., McGovern D., Macchi M., Cho J.H., Shouval D.S., Kammermeier J., Koletzko S., Bagalopal K., Capitani M., Cavounidis A., Pires E., Weidinger C., McCullagh J., Arkwright P.D., Haller W., Siegmund B., Peters L., Jostins L., Travis S., Anderson C.A., Snapper S.B., Klein C., Schadt E.E., Uhlig H.H., et al.

    Gastroenterology

    2021 cited 100